Effects of intravenous administration of pirfenidone on horses with experimentally induced endotoxemia.

The research article concerns the study of how the intravenous administration of a drug called pirfenidone affects horses that have been experimentally induced with endotoxemia. However, the results showed that the drug had no protective effects against the systemic effects of the condition.

Experimental Design

• The study involved 18 healthy adult horses that were randomly divided into three groups, with each group containing six horses.
• A mixture of either a low dose of endotoxin or saline solution was intravenously administered to the horses over a period of 30 minutes. The mixture given to the ‘Lipopolysaccharide-pirfenidone’ group consisted of endotoxin followed by pirfenidone, while the ‘Lipopolysaccharide-saline’ group received endotoxin followed by saline solution. The final group, ‘Saline-pirfenidone’, was treated with saline solution followed by pirfenidone.
• Physical examinations results and blood samples were collected at different intervals throughout a 24-hour study period. The blood samples were used to conduct complete blood count (CBC), biochemical analyses, and measurements of tumor necrosis factor-alpha (TNF-alpha) concentrations.

Results and Conclusion

• Administration of pirfenidone after a low dose of endotoxin did not lower the clinical, clinicopathologic, or cytokine alterations that developed as a result of endotoxin exposure.
• When pirfenidone was infused after saline solution, it caused only mild and temporary clinical signs, but did not bring about any associated clinicopathologic changes.
• The research found that pirfenidone was tolerated and only caused mild temporary clinical adverse effects during infusion. However, it did not provide any protection to horses from the systemic effects of experimentally induced endotoxemia.
• The researchers conclude that further studies may be needed to investigate related, but more potent, drugs.